Clinicians and Patients Speak to the Efficacy, Safety and Value of Glytec’s eGlycemic Management System.
Successfully transitioning from sliding scale to basal bolus: Truths behind the journey and the results. Kaweah Delta Health Care District. Download a PDF of this compelling case study showcasing how Kaweah Delta Health Care District partnered with Glytec to achieve best practices in glycemic management.Download PDFSuccessfully transitioning from sliding scale to basal bolus: Truths behind the journey and the results. …
Virtual diabetes care: Unlocking the keys to real results. Dr. Ronald Dixon of Onduo and Dr. Andrew Rhinehart of Glytec. Hosted by HIMSS.
What do hospital executives say about using Glytec’s eGMS to combat the cost, quality and safety issues surrounding hypoglycemia?
Improvements in quality and safety of patient care through changes to insulin management protocols, including the transition from Monarch Medical Technologies’ EndoTool to Glytec’s Glucommander. MedPage Today interviews Dr. Valerie Garrett.
Using Glucommmander Outpatient for insulin titration between office visits helps patients reach A1C goals. MD Magazine interviews Dr. Bruce Bode.
Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.
Data sharing capabilities with connected devices allows for more efficient and timely insulin dosing recommendations. AJMC interviews Robby Booth, Senior Vice President Research & Development at Glytec.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, operations perspective. Audrey Douglas-Cooke, Vice President Operations and Associate Nursing Executive.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, nursing perspective. Margaret Bachand, Diabetes Center Manager; Evelyn Olenick, Vice President Patient Care Services; and Grace Pagtakhan, former Clinical Nurse II.
Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.
Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.
How eGMS enables subcutaneous basal bolus insulin therapy and overcomes difficulties of meal-to-meal dosing adjustments. MD Magazine interviews Dr. Jagdeesh Ullal.
How Glytec’s evidence strategy achieves improvements in lengths of stay, readmissions, infections and costs. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.
- Page 2 of 2